AU4182300A - Soluble recombinant endostatin - Google Patents

Soluble recombinant endostatin

Info

Publication number
AU4182300A
AU4182300A AU41823/00A AU4182300A AU4182300A AU 4182300 A AU4182300 A AU 4182300A AU 41823/00 A AU41823/00 A AU 41823/00A AU 4182300 A AU4182300 A AU 4182300A AU 4182300 A AU4182300 A AU 4182300A
Authority
AU
Australia
Prior art keywords
soluble recombinant
recombinant endostatin
endostatin
soluble
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41823/00A
Inventor
Judith A. Boice
Barbara Leiting
John F O'connell
David L. Pompliano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU4182300A publication Critical patent/AU4182300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
AU41823/00A 1999-03-30 2000-03-23 Soluble recombinant endostatin Abandoned AU4182300A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12680699P 1999-03-30 1999-03-30
US60126806 1999-03-30
US12848999P 1999-04-09 1999-04-09
US60128489 1999-04-09
PCT/US2000/008435 WO2000058498A1 (en) 1999-03-30 2000-03-29 Soluble recombinant endostatin

Publications (1)

Publication Number Publication Date
AU4182300A true AU4182300A (en) 2000-10-16

Family

ID=26825046

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41823/00A Abandoned AU4182300A (en) 1999-03-30 2000-03-23 Soluble recombinant endostatin

Country Status (2)

Country Link
AU (1) AU4182300A (en)
WO (1) WO2000058498A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2526036A1 (en) * 2003-05-20 2004-12-02 Pfizer Products Inc. Methods and compositions for diagnosing and treating disorders involving angiogenesis
CN1724671B (en) * 2005-07-04 2011-07-20 山东东阿阿胶股份有限公司 Recombination human endothelium chalene expression strain and solubility expression method
CN103992400B (en) * 2014-05-29 2017-01-04 江苏吴中医药集团有限公司苏州中凯生物制药厂 The renaturation solution of Research of Recombinant Human Endostatin and preparation, using method
CN105218660B (en) * 2014-07-03 2019-02-12 苏州方舟基因药业有限公司 The novel purification renaturation method and its antitumor application thereof of Recombinant Endostatin
CN106674352B (en) * 2015-11-10 2020-05-15 孙嘉琳 Derivative of antineoplastic protein endostatin and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854205A (en) * 1995-10-23 1998-12-29 The Children's Medical Center Corporation Therapeutic antiangiogenic compositions and methods
US6653098B1 (en) * 1998-02-23 2003-11-25 G. D. Searle & Co. Method of producing mouse and human endostatin

Also Published As

Publication number Publication date
WO2000058498A1 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
AU3242400A (en) Dual stage inflator
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU1317801A (en) Dual-polarised antenna
AU2678800A (en) Modified calycins
AU2965600A (en) Interleukin-20
AU5967600A (en) Candystraw
AU4115400A (en) Short-circuiter
AU2023701A (en) Sketcher
AU2699800A (en) Organoceramics
AU5706000A (en) Useful polypeptide
AU3174900A (en) Antenna
AU4916900A (en) Benzofuranylsulfonates
AU4182300A (en) Soluble recombinant endostatin
AU3473800A (en) Conotoxin peptides
AU4561600A (en) Benzofuranylaminoalcohols
AU2691500A (en) Novel polypeptide
AU5903000A (en) Novel anti-thrombin peptide
AU4778600A (en) Novel polypeptide
AU1901801A (en) Glucofuranoses
AU4435300A (en) Hula-hoop
AU2582200A (en) Windturbine
AU1915601A (en) Periotome
AU2109200A (en) Polypeptide
AU6319600A (en) Patch

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase